Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
General Motors Financial $2.5 billion senior notes offering
The investment-grade notes are due 2025 and 2029
Charles River Laboratories $295 million acquisition of Explora BioLabs Holdings
We advised Charles River on the transaction
Equinix $1.2 billion green bonds offering
We advised Equinix on the investment-grade debt offering
Grupo Aval spinoff of BAC Holding International
We advised Grupo Aval on the unregistered spinoff of a 75% equity stake in its indirect subsidiary
Incora comprehensive recapitalization transaction
We advised an ad hoc group of secured noteholders on the recapitalization
Monarch Alternative Capital $150 million investment in The Honest Kitchen
We are advising Monarch Alternative Capital on the transaction
SPX FLOW $500 million senior notes offering
The high-yield notes were issued in connection with Lone Star’s financing for the acquisition of SPX FLOW
Workday $3 billion senior notes offering
The investment-grade notes are due 2027, 2029 and 2032
YUM! Brands $1 billion senior notes offering
The high-yield notes are due 2032
Bank of America C$350 million reopening of fixed-to-floating-rate notes
The investment-grade notes are due 2028